[ad_1]
The American pharmaceutical company Pfizer and its partner BioNTech submitted an official application to the United States Food and Drug Administration (FDA) last Friday for the emergency use of the Covid-19 vaccine they developed.
The FDA Vaccine Advisory Committee is expected to meet on December 10. President of the US Covid-19 Vaccine Program Moncef Slaoui told the US media that his plans were “to send the vaccines to the vaccine areas within 24 hours of the approval of the vaccine.” Slaoui stated that the vaccine could be released “on December 11 or 12, perhaps two days after approval.”
ADVERTISED TO BE 95 PERCENT EFFECTIVE
US pharmaceutical giant Pfizer and German biotech company BioNTech announced on November 18 that the coronavirus vaccine “BNT162b1”, which they developed jointly, was 95 percent effective in preventing the virus.
While the US Centers for Disease Control and Prevention (CDC) warns that coronavirus cases are “increasing rapidly” across the country, they urged citizens to refrain from traveling for the holiday. Thanksgiving on November 26. In the US, casualties due to Covid-19 have reached the highest level since May. (İHA)
The total number of cases in the US reached 12,471,316 and the total loss of life reached 261,932.
It may interest you
It may interest you
[ad_2]
